Differential bidirectional transfer of indinavir in the isolated perfused human placenta. - Wikidata - wikimedia - TriplyDB

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

http://www.wikidata.org/entity/Q33857508

about

Effects of rifampicin, dexamethasone, St. John's Wort and Thyroxine on maternal and foetal expression of Abcb1 and organ distribution of talinolol in pregnant rats Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy.Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.ATP-binding cassette efflux transporters in human placenta.Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy.Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model.Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples.Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Regulation of drug transporter expression and function in the placenta.Prescribing in pregnancy and lactation.The role of the placenta in drug transport and fetal drug exposure.

P2860

Q28568297-3DE780C4-2FD3-4936-8D47-75EB5EE4B0ED Q33954823-0AEC9AA4-D57B-400C-A883-5625F8F1A47F Q34429204-1D61399C-3F78-412B-937B-5976474E1754 Q34843023-9A9AC27C-D37E-4C30-A9B3-CDAECFAB76C0 Q34983809-81ECF9FA-B447-463A-8857-665C5F268D07 Q36025069-4356E844-AAE8-490A-963A-23858BEF7270 Q36350868-93C3E593-6AB1-4DC1-97BF-6868AD241C6E Q36388061-6C50B4C9-041A-4CE5-A3E1-7A2E2C15477A Q36729133-8A8470B1-EC21-4DB0-920B-4AECBB39E8A1 Q37423787-61FE9403-5181-4ABD-8B22-D248E1D9ED39 Q37790379-E6AD7F20-C7FD-4883-9AB6-8FCB0E12CEFB Q37874439-B268DFD3-81E2-45A8-AB04-9502B5824202 Q38044958-6396937C-58EF-4E11-B1AA-DE7250BAE03F Q38323562-F8163FFC-74E0-4CBC-AA64-3C6BBEDB189B Q43213916-ACA83AD9-F196-4F86-AEDC-299936B442DD Q47201255-F08A7479-3C13-4CD8-BC6B-A436EDA079BF

P2860

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

http://www.wikidata.org/entity/Q33857508

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@ast

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@en

type

label

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@ast

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@en

prefLabel

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@ast

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@en

P1433

Q33857508-A799FCDA-F967-4DEE-AC32-59B48D29E4E5

P1476

Q33857508-779F2928-2551-4E87-A017-265CC0912ABF

P2093

Q33857508-0468ABAC-37F1-49EF-A0EB-3FB5FEA49177

Q33857508-1ADD3B52-680E-4E8E-821B-469CCFCFD608

Q33857508-62288B66-AA50-4F4A-B6CA-24FDA1694B2E

Q33857508-A6B0753B-E7A7-4EE5-8DCF-3E642049DF2B

Q33857508-CF41D7D3-B493-4E0D-9D74-77FFAEB37359

Q33857508-D8F6BBE6-F347-41C4-B945-45C2680F6DAB

Q33857508-EE2950BB-C0BC-4CB9-B94E-AC605FBB95E9

P2860

Q33857508-1C7DCC22-49D1-4791-89CC-6E91DFA8BD16

Q33857508-200921C1-E2FA-4AA7-9351-CCE7FE33BDD1

Q33857508-219699A5-AB58-47C6-B99F-94DC6E2844A0

Q33857508-29819480-3128-4F89-B553-F290FC4067CB

Q33857508-2CE5DED4-008D-4C80-ACA8-B810269F3725

Q33857508-3307D67A-BA70-4AC2-A644-0EE4129ECB94

Q33857508-3DFBBF04-B712-4C5E-99BB-922BE8BA63FC

Q33857508-53CC26A2-630A-406A-9F41-6218E562882A

Q33857508-6755AFEF-6D47-4FB6-B8CA-B28794FB3AA8

Q33857508-706E6A02-B378-46BF-91B7-DC540AF1B9C0

P304

Q33857508-AFB352A0-69DC-4F69-804C-43FDC82459ED

P31

Q33857508-A01B2998-78E3-4652-9371-244491EF778A

P356

Q33857508-D97D5237-DF67-4A15-90F1-29FB11928961

P407

Q33857508-F3EEB5FC-800E-42A7-B236-26B8A7FEB5BC

P433

Q33857508-166D7BDB-4041-4D2E-BB14-92E0014404F6

P478

Q33857508-4F1536C5-E1D1-46BB-8C50-AE0786F49DFB

P577

Q33857508-A952F4C4-89AE-47BD-80D1-6423D26627F8

P5875

Q33857508-C1E27C8B-3C84-42AD-9216-427F7D4C4952

P698

Q33857508-AA853B54-50F6-4530-8EE9-B86D53626026

P932

Q33857508-F8594F61-9DA1-4E56-BC54-4EF132538C37

P356

AAC.49.3.1023-1028.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

@en

P2093

Craig R Rayner

http://www.w3.org/2001/XMLSchema#string

David C M Kong

http://www.w3.org/2001/XMLSchema#string

Hany Ghabrial

http://www.w3.org/2001/XMLSchema#string

Neil M Gude

http://www.w3.org/2001/XMLSchema#string

Peter W Angus

http://www.w3.org/2001/XMLSchema#string

Roger L Nation

http://www.w3.org/2001/XMLSchema#string

Sreeja Sudhakaran

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Multicenter review of protease inhibitors in 89 pregnancies.

The role of therapeutic drug monitoring in treatment of HIV infection.

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Role of P-glycoprotein in pharmacokinetics: clinical implications.

Efflux transporters of the human placenta.

The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir.

P304

1023-1028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.3.1023-1028.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8004583

http://www.w3.org/2001/XMLSchema#string

P698

15728898

http://www.w3.org/2001/XMLSchema#string

P932

549249

http://www.w3.org/2001/XMLSchema#string